20-36878008-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080628.3(TLDC2):āc.143A>Gā(p.Gln48Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_080628.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TLDC2 | NM_080628.3 | c.143A>G | p.Gln48Arg | missense_variant | 2/7 | ENST00000217320.8 | |
TLDC2 | NM_001304783.1 | c.143A>G | p.Gln48Arg | missense_variant | 2/6 | ||
TLDC2 | XM_017027674.2 | c.-141A>G | 5_prime_UTR_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TLDC2 | ENST00000217320.8 | c.143A>G | p.Gln48Arg | missense_variant | 2/7 | 1 | NM_080628.3 | P1 | |
TLDC2 | ENST00000602922.5 | c.143A>G | p.Gln48Arg | missense_variant | 2/6 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000195 AC: 49AN: 251022Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135672
GnomAD4 exome AF: 0.000139 AC: 203AN: 1461774Hom.: 0 Cov.: 31 AF XY: 0.000166 AC XY: 121AN XY: 727188
GnomAD4 genome AF: 0.000171 AC: 26AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.143A>G (p.Q48R) alteration is located in exon 2 (coding exon 2) of the TLDC2 gene. This alteration results from a A to G substitution at nucleotide position 143, causing the glutamine (Q) at amino acid position 48 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at